Skip to main content

Advertisement

SpringerLink
Log in

Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Although, staging models gained momentum to stage define affective disorders, no attempts were made to construct mathematical staging models using clinical and biomarker data in patients with major depression and bipolar disorder. The aims of this study were to use clinical and biomarker data to construct statistically derived staging models, which are associated with early lifetime traumata (ELTs), affective phenomenology, and biomarkers. In the current study, 172 subjects participated, 105 with affective disorders (both bipolar and unipolar) and 67 controls. Staging scores were computed by extracting latent vectors (LVs) from clinical data including ELTs, recurring flare ups and suicidal behaviors, outcome data such as disabilities and health-related quality of life (HR-QoL), and paraoxonase (PON)1 actvities and nitro-oxidative stress biomarkers. Recurrence of episodes and suicidal behaviors could reliably be combined into a LV with adequate composite reliability (the “recurrence LV”), which was associated with female sex, the combined effects of multiple ELTs, disabilities, HR-QoL, and impairments in cognitive tests. All those factors could be combined into a reliable “ELT-staging LV” which was significantly associated with nitro-oxidative stress biomarkers. A reliable LV could be extracted from serum PON1 activities, recurrent flare ups, disabilities, and HR-QoL. Our ELT-staging index scores the severity of a relevant affective dimension, shared by both major depression and bipolar disorder, namely the trajectory from ELTs, a relapsing course, and suicidal behaviors to progressive disabilities. Patients were classified into three stages, namely an early stage, a relapse-regression stage, and a suicidal-regression stage. Lowered lipid-associated antioxidant defenses may be a drug target to prevent the transition from the early to the later regression stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ANOVA:

Analysis of variance

AOPP:

Advanced protein oxidation product

APA:

American Psychiatric Association

AVE:

Average variance extracted

BD:

Bipolar disorder

BMI:

Body mass index

CGI:

Clinical Global Impression

C-SSRS:

Columbia–Suicide Severity Rating Scale

CTQ:

Childhood Trauma Questionnaire

ELT:

Early lifetime traumata

GAD:

Generalized anxiety disorder

HAM-A:

Hamilton Anxiety Rating Scale

HAM-D:

Hamilton Depression Rating Scale

HDL:

High-density lipoprotein

HOC:

Higher order construct

HR-QoL:

Health-related quality of life

CRP:

C-reactive protein

LCAT:

Lecithin cholesterol acyltransferase

LOOH:

Lipid hydroperoxides

LV:

Latent vector

MDA:

Malondialdehyde

MDD:

Major depression

MetS:

The metabolic syndrome

NOx:

NO metabolites

O&NS:

Oxidative and nitrosative stress

OD:

Optical density

PLS:

Partial least squares

PON:

Paraoxonase

RLU:

Relative units of light

ROS/RNS:

Reactive oxygen and nitrogen species

SOD:

Superoxide dismutase

SRMR:

Standardized root mean residual

TMT:

Trail-making test

TRD:

Treatment resistant depression

TSH:

Thyroid-stimulating hormone

TUD:

Tobacco use disorder

UA:

Uric acid

VFT:

Verbal fluency test

WHOQOL-BREF:

WHO Quality of Life Instrument-Abbreviated Version

YMRS:

Young Mania Rating Scale

References

  1. Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P et al (2011) Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 13(1):87–98

    Article  PubMed  Google Scholar 

  2. Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P (2013) Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 202(4):243–245

    Article  PubMed  Google Scholar 

  3. Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18(5):595–606

    Article  CAS  PubMed  Google Scholar 

  4. Muneer A (2016) Staging models in bipolar disorder: a systematic review of the literature. Clin Psychopharmacol Neurosci 31(2):117–130

    Article  Google Scholar 

  5. Mwangi B, Wu MJ, Cao B, Passos IC, Lavagnino L, Keser Z, Zunta-Soares GB, Hasan KM et al (2016) Individualized prediction and clinical staging of bipolar disorders using neuroanatomical biomarkers. Biol Psychiatry Cogn Neurosci Neuroimaging 1(2):186–194

    Article  PubMed  PubMed Central  Google Scholar 

  6. Passos IC, Kapczinski F (2017) Should bipolar disorder treatment be modified depending on staging? Expert Rev Neurother 17(2):93–95

    Article  CAS  PubMed  Google Scholar 

  7. Maes M, Congio A, Moraes JB, Bonifacio KL, Barbosa DS, Vargas HO, Morris G, Puri BK et al (2018) Early life trauma predicts affective phenomenology and the effects are partly mediated by staging coupled with lowered lipid-associated antioxidant defences. Biomol Concepts 9(1):115–130

    Article  CAS  PubMed  Google Scholar 

  8. Cosci F, Fava GA (2013) Staging of mental disorders: systematic review. Psychother Psychosom 82(1):20–34

    Article  PubMed  Google Scholar 

  9. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A et al (2014) Stage managing bipolar disorder. Bipolar Disord 16(5):471–417

    Article  PubMed  Google Scholar 

  10. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E, Berk M (2009) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 33(8):1366–1371

    Article  CAS  Google Scholar 

  11. Ferensztajn E, Remlinger-Molenda A, Rybakowski J (2014) Staging of unipolar affective illness. Psychiatr Pol 48(6):1127–1141

    Article  PubMed  Google Scholar 

  12. Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, Nunes SOV (2018) Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol 56:141–156. https://doi.org/10.1007/s12035-018-1051-7

    Article  CAS  PubMed  Google Scholar 

  13. Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55(12):8885–8903

    Article  CAS  PubMed  Google Scholar 

  14. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry 19(1):11–38

    Article  CAS  Google Scholar 

  15. Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36(2):764–785

    Article  CAS  PubMed  Google Scholar 

  16. Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):676–692

    Article  CAS  Google Scholar 

  17. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43(5):315–319

    Article  CAS  PubMed  Google Scholar 

  18. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38(1):35–46

    Article  CAS  PubMed  Google Scholar 

  19. Maes M, Delanghe J, Meltzer HY, Scharpé S, D'Hondt P, Cosyns P (1994) Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 90(4):252–258

    Article  CAS  PubMed  Google Scholar 

  20. Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A et al (1997) Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 95(3):212–221

    Article  CAS  PubMed  Google Scholar 

  21. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A (2000) Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58(3):241–246

    Article  CAS  PubMed  Google Scholar 

  22. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Lower plasma coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 30(4):462–469

    CAS  PubMed  Google Scholar 

  23. Sobczak S, Honig A, Christophe A, Maes M, Helsdingen RW, De Vriese SA, Riedel WJ (2004) Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients. Psychol Med 34(1):103–112

    Article  CAS  PubMed  Google Scholar 

  24. Tsuboi H, Tatsumi A, Yamamoto K, Kobayashi F, Shimoi K, Kinae N (2006) Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 91(1):63–70

    Article  CAS  PubMed  Google Scholar 

  25. Nunes SO, Piccoli de Melo LG, Pizzo de Castro MR, Barbosa DS, Vargas HO, Berk M, Maes M (2015) Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J Affect Disord 172:55–62

    Article  CAS  PubMed  Google Scholar 

  26. Moreira EG, Correia DG, Bonifácio KL, Moraes JB, Cavicchioli FL, Nunes CS, Nunes SOV, Vargas HO et al (2017) Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life. World J Biol Psychiatry 30:1–13

    Google Scholar 

  27. Bilici M, Efe H, Köroğlu MA, Uydu HA, Bekaroğlu M, Değer O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64(1):43–51

    Article  CAS  PubMed  Google Scholar 

  28. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2010) Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord 125(1–3):287–294

    Article  CAS  PubMed  Google Scholar 

  29. Morris G, Walder K, Puri BK, Berk M, Maes M (2016) The deleterious effects of oxidative and Nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in Neuroimmune disorders. Mol Neurobiol 53(7):4638–4658

    Article  CAS  PubMed  Google Scholar 

  30. Maes M, Mihaylova I, Kubera M, Ringel K (2012) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 36(1):169–175

    Article  Google Scholar 

  31. Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G et al (2018) Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuro-Psychopharmacol Biol Psychiatry 81:372–383

    Article  CAS  Google Scholar 

  32. de Melo LGP, Nunes SOV, Anderson G, Vargas HO, Barbosa DS, Galecki P, Carvalho AF, Maes M (2017) Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 78:34–50

    Article  CAS  Google Scholar 

  33. Nunes CS, Maes M, Roomruangwong C, Moraes JB, Bonifacio KL, Vargas HO, Barbosa DS, Anderson G et al (2018) Lowered quality of life in mood disorders is associated with increased neuro-oxidative stress and basal thyroid-stimulating hormone levels and use of anticonvulsant mood stabilizers. J Eval Clin Pract 24(4):869–878

    Article  PubMed  Google Scholar 

  34. Del-Ben CM, Vilela JAA, de S Crippa JA, JEC H, Labate CM et al (2001) Confiabilidade da “Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica” traduzida para o português. Rev Bras Psiquiatr 23:156–159

    Article  Google Scholar 

  35. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Author, Washington, DC

    Google Scholar 

  36. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55

    Article  CAS  PubMed  Google Scholar 

  37. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Vilela JA, Crippa JA, Del-Ben CM, Loureiro SR (2005) Reliability and validity of a Portuguese version of the young mania rating scale. Braz J Med Biol Res 38(9):1429–1439

    Article  CAS  PubMed  Google Scholar 

  39. Sheehan DV, Harnett-Sheehan K, Raj BA (1996) The measurement of disability. Int Clin Psychopharmacol 11(Suppl 3):89–95

    Article  PubMed  Google Scholar 

  40. WHO (1993) Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 2(2):153–159

    Article  Google Scholar 

  41. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group (2004) The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 13(2):299–310

    Article  CAS  PubMed  Google Scholar 

  42. Fleck MP, Louzada S, Xavier M et al (2000) Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica 34(2):178–183

    Article  CAS  PubMed  Google Scholar 

  43. Guy W (1976) “Clinical global impressions”. ECDEU assessment manual for psychopharmacology—revised. U.S. Department of Health, Education, and Welfare; Public Health Service, Alcohol; Drug Abuse, and Mental Health Administration; National Institute of Mental Health; Psychopharmacology Research Branch; Division of Extramural Research Programs, Rockville, pp. 218–222

    Google Scholar 

  44. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA et al (2011) The Columbia-suicide severity rating scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168(12):1266–1277

    Article  PubMed  PubMed Central  Google Scholar 

  45. Jensen A (1965) Scoring the Stroop test. Acta Psychol 24:398–408

    Article  Google Scholar 

  46. Reitan RM (1958) Validity of The trail making test as an indication of organic brain damage. Percept Motor Skills 8:271–276

    Article  Google Scholar 

  47. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L et al (2003) Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl 27(2):169–190

    Article  PubMed  Google Scholar 

  48. Grassi-Oliveira R, Stein LM, Pezzi JC (2006) Translation and content validation of the childhood trauma questionnaire into Portuguese language. Rev Saude Publica 40:249–255

    Article  PubMed  Google Scholar 

  49. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191–2192

    Article  CAS  PubMed  Google Scholar 

  50. Marklund S, Marklund G (1974) Involvement of the superoxide dismutase anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–471

    Article  CAS  PubMed  Google Scholar 

  51. Gonzalez Flecha B, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10:93–100

    Article  CAS  PubMed  Google Scholar 

  52. Panis C, Herrera ACSA, Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simao AN, Cecchini AL et al (2012) Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133:89–97

    Article  CAS  PubMed  Google Scholar 

  53. Navarro-Gonzalvez JA, Garcia-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44:679–681

    CAS  PubMed  Google Scholar 

  54. Hanasand M, Omdal R, Norheim KB, Gransson LG, Brede C, Jonsson G (2012) Improved detection of advanced oxidation protein products in plasma. Clin Chim Acta 413:901–906

    Article  CAS  PubMed  Google Scholar 

  55. Bastos AS, Loureiro AP, de Oliveira TF, Corbi SC, Caminaga RM, Junior CR, Orrico SR (2012) Quantitation of malondialdehyde in gingival crevicular fluid by a high-performance liquid chromatography-based method. Anal Biochem 423:141–146

    Article  CAS  PubMed  Google Scholar 

  56. Ringle CM, Wende S, Becker J-M (2015) SmartPLS 3. SmartPLS, Bönningstedt Retrieved (29-11-2018) from http://www.smartpls.com

    Google Scholar 

  57. Marangoni C, Hernandez M, Faedda GL (2016) The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies. J Affect Disord 193:165–174

    Article  CAS  PubMed  Google Scholar 

  58. Catone G, Marwaha S, Kuipers E, Lennox B, Freeman D, Bebbington P, Broome M (2015) Bullying victimisation and risk of psychotic phenomena: analyses of British national survey data. Lancet Psychiatry 2:618–624

    Article  PubMed  Google Scholar 

  59. Fisher HL, Jones PB, Fearon P, Craig TK, Dazzan P, Morgan K, Hutchinson G, Doody GA et al (2010) The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder. Psychol Med 40:1967–1978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Takizawa R, Maughan B, Arseneault L (2014) Adult health outcomes of childhood bullying victimization: evidence from a five-decade longitudinal British birth cohort. Am J Psychiatry 171:777–784

    Article  PubMed  Google Scholar 

  61. Alvarez MJ, Roura P, Oses A, Foguet Q, Sola J, Arrufat FX (2011) Prevalence and clinical impact of childhood trauma in patients with severe mental disorders. J Nerv Ment Dis 199:156–161

    Article  PubMed  Google Scholar 

  62. Bergink V, Larsen JT, Hillegers MH, Dahl SK, Stevens H, Mortensen PB, Petersen L, Munk-Olsen T (2016) Childhood adverse life events and parental psychopathology as risk factors for bipolar disorder. Transl Psychiatry 6:e929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Heim C, Shugart M, Craighead WE, Nemeroff CB (2010) Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol 52:671–690

    Article  PubMed  Google Scholar 

  64. Larsson S, Andreassen OA, Aas M, Røssberg JI, Mork E, Steen NE, Barrett EA, Lagerberg TV et al (2013) High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder. Compr Psychiatry 54(2):123–127

    Article  PubMed  Google Scholar 

  65. Etain B, Lajnef M, Henry C, Aubin V, Azorin JM, Bellivier F, Bougerol T, Courtet P et al (2017) Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis. J Psychiatr Res 95:37–45

    Article  CAS  PubMed  Google Scholar 

  66. Widom CS, DuMont K, Czaja SJ (2007) A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 64(1):49–56

    Article  PubMed  Google Scholar 

  67. Tanskanen A, Hintikka J, Honkalampi K, Haatainen K, Koivumaa-Honkanen H, Viinamäki H (2004) Impact of multiple traumatic experiences on the persistence of depressive symptoms—a population-based study. Nord J Psychiatry 58(6):459–464

    Article  PubMed  Google Scholar 

  68. Negele A, Kaufhold J, Kallenbach L, Leuzinger-Bohleber M (2015) Childhood trauma and its relation to chronic depression in adulthood. Depress Res Treat 2015:650804

    PubMed  PubMed Central  Google Scholar 

  69. Aas M, Henry C, Bellivier F, Lajnef M, Gard S, Kahn JP, Lagerberg TV, Aminoff SR et al (2017) Affective lability mediates the association between childhood trauma and suicide attempts, mixed episodes and co-morbid anxiety disorders in bipolar disorders. Psychol Med 47(5):902–912

    Article  CAS  PubMed  Google Scholar 

  70. Moraes JB, Maes M, Barbosa DS, Ferrari TZ, Uehara MKS, Carvalho AF, Nunes SOV (2017) Elevated C-reactive protein levels in women with bipolar disorder may be explained by a history of childhood trauma, especially sexual abuse, body mass index and age. CNS Neurol Disord Drug Targets 16(4):514–521

    Article  CAS  PubMed  Google Scholar 

  71. Janiri D, Sani G, Danese E, Simonetti A, Ambrosi E, Angeletti G, Erbuto D, Caltagirone C et al (2015) Childhood traumatic experiences of patients with bipolar disorder type I and type II. J Affect Disord 175:92–97

    Article  PubMed  Google Scholar 

  72. American Psychiatric Association (2013) Bipolar disorder. In: Diagnostic and Statistical Manual of Mental Disorders (5th ed), p 571–577

  73. Bolton JM, Gunnell D, Turecki G (2015) Suicide risk assessment and intervention in people with mental illness. BMJ 351:h4978

    Article  PubMed  Google Scholar 

  74. Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E (2013) Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci Biobehav Rev 37(10 Pt 1):2372–2374

    Article  PubMed  Google Scholar 

  75. Novick DM, Swartz HA, Frank E (2010) Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 12(1):1–9

    Article  PubMed  PubMed Central  Google Scholar 

  76. Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, Grant BF, Blanco C (2012) Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on alcohol and related conditions. Bipolar Disord 14(3):271–282

    Article  PubMed  PubMed Central  Google Scholar 

  77. Perlis RH, Brown E, Baker RW, Nierenberg AA (2006) Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry 163(2):225–231

    Article  PubMed  Google Scholar 

  78. Murray CJ, Vos T, Lozano R et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2197–2223

    Article  PubMed  Google Scholar 

  79. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367(9524):1747–1757

    Article  PubMed  Google Scholar 

  80. Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE (2010) Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety 27:78–89

    Article  PubMed  Google Scholar 

  81. Dean BB, Gerner D, Gerner RH (2004) A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 20:139–154

    Article  PubMed  Google Scholar 

  82. Depp CA, Mausbach BT, Harmell AL, Savla GN, Bowie CR, Harvey PD, Patterson TL (2012) Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord 14:217–226

    Article  PubMed  PubMed Central  Google Scholar 

  83. GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study. Lancet 388:1603–1658

    Article  Google Scholar 

  84. Agnew-Blais J, Danese A (2016) Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 3(4):342–349

    Article  PubMed  Google Scholar 

  85. Jansen K, Cardoso TA, Fries GR, Branco JC, Silva RA, Kauer-Sant'Anna M, Kapczinski F, Magalhaes PV (2016) Childhood trauma, family history, and their association with mood disorders in early adulthood. Acta Psychiatr Scand 134:281–286

    Article  CAS  PubMed  Google Scholar 

  86. Hadland SE, Marshall BD, Kerr T, Qi J, Montaner JS, Wood E (2012) Suicide and history of childhood trauma among street youth. J Affect Disord 136:377–380

    Article  PubMed  Google Scholar 

  87. Roy A, Janal M (2005) Family history of suicide, female sex, and childhood trauma: separate or interacting risk factors for attempts at suicide? Acta Psychiatr Scand 112:367–371

    Article  CAS  PubMed  Google Scholar 

  88. Krug EG, Dahlberg LL, Mercy J, Zwi A, Lozano R (2002) Child abuse and neglect by parents and other caregivers. World Health Organization. World Report on Violence and Health, pp 59–86

  89. Schoedl AF, Costa MC, Mari JJ, Mello MF, Tyrka AR, Carpenter LL, Price LH (2010) The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults. J Child Sex Abus 19:156–170

    Article  PubMed  PubMed Central  Google Scholar 

  90. Ventegodt S, Flensborg-Madsen T, Andersen NJ, Merrick J (2008) Which factors determine our quality of life, health and ability? Results from a Danish population sample and the Copenhagen perinatal cohort. J Coll Physicians Surg Pak 18(7):445–450

    PubMed  Google Scholar 

  91. Erten E, Funda Uney A, Saatçioğlu Ö, Özdemir A, Fıstıkçı N, Çakmak D (2014) Effects of childhood trauma and clinical features on determining quality of life in patients with bipolar I disorder. J Affect Disord 162:107–113

    Article  PubMed  Google Scholar 

  92. Afifi TO, Enns MW, Cox BJ, de Graaf R, ten Have M, Sareen J (2007) Child abuse and health-related quality of life in adulthood. J Nerv Ment Dis 195:797–804

    Article  PubMed  Google Scholar 

  93. Chahine EF (2014) Child abuse and its relation to quality of life of male and female children. Procedia Soc Behav Sci 159:161–168

    Article  Google Scholar 

  94. Pechtel P, Pizzagalli DA (2011) Effects of early life stress on cognitive and affective function: an integrated review of human literature. Psychopharmacology 214(1):55–70

    Article  CAS  PubMed  Google Scholar 

  95. Kaplan GA, Turrell G, Lynch JW, Everson SA, Helkala EL, Salonen JT (2001) Childhood socioeconomic position and cognitive function in adulthood. Int J Epidemiol 30(2):256–263

    Article  CAS  PubMed  Google Scholar 

  96. Hepgul N, Pariante CM, Dipasquale S, DiForti M, Taylor H, Marques TR, Morgan C, Dazzan P et al (2012) Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients. Psychol Med 42(9):1893–1901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Danese A, Tan M (2014) Childhood maltreatment and obesity: systematic review and meta-analysis. Mol Psychiatry 19(5):544–554

    Article  CAS  PubMed  Google Scholar 

  98. Kim JH, Kwon JW (2012) The impact of health-related quality of life on suicidal ideation and suicide attempts among Korean older adults. J Gerontol Nurs 38(11):48–59

    Article  PubMed  Google Scholar 

  99. Bowden CL (2005) Bipolar disorder and work loss. Am J Manag Care 11(3 Suppl):S91–S94

    PubMed  Google Scholar 

  100. Michalak EE, Yatham LN, Lam RW (2005) Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 3:72

    Article  PubMed  PubMed Central  Google Scholar 

  101. Woo JM, Jeon HJ, Noh E, Kim HJ, Lee SW, Lee KK, Kim SH, Hong JP (2014) Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study. Health Qual Life Outcomes 12:188

    Article  PubMed  PubMed Central  Google Scholar 

  102. Moraes JB, Maes M, Roomruangwong C, Bonifacio KL, Barbosa DS, Vargas HO, Anderson G, Kubera M et al (2018) In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life. Metab Brain Dis 33(4):1081–1096

    Article  CAS  PubMed  Google Scholar 

  103. Cohen-Woods S, Fisher HL, Ahmetspahic D, Douroudis K, Stacey D, Hosang GM, Korszun A, Owen M et al (2018) Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples. Brain Behav Immun 67:203–210

    Article  CAS  PubMed  Google Scholar 

  104. Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M et al (2010) The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 34(2):372–375

    Article  CAS  Google Scholar 

  105. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA et al (2014) Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46–62

    Article  CAS  PubMed  Google Scholar 

  106. Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q et al (2015) Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis. Schizophr Res 166(1–3):225–230

    Article  PubMed  Google Scholar 

  107. Vargas HO, Nunes SO, Pizzo de Castro M, Bortolasci CC, Sabbatini Barbosa D, Kaminami Morimoto H, Venugopal K, Dodd S et al (2013) Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 150:923–930

    Article  CAS  PubMed  Google Scholar 

  108. Gałecki P, Talarowska M, Anderson G, Berk M, Maes M (2015) Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. Med Sci Monit 21:1535–1547

    Article  PubMed  PubMed Central  Google Scholar 

  109. Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M (2015) C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry 76(2):142–150

    Article  PubMed  Google Scholar 

  110. Stojanov D, Korf J, Jonge P, Popov G (2011) The possibility of evidence-based psychiatry: depression as a case. Clin Epigenetics 2(1):7–15

    Article  PubMed  Google Scholar 

  111. Stojanov D, Machamer PK, Schaffner KF, Rivera-Hernández R (2012) The challenge of psychiatric nosology and diagnosis. J Eval Clin Pract 18(3):704–709

    Article  Google Scholar 

  112. Maes M, Schotte C, Maes L, Cosyns P (1990) Clinical subtypes of unipolar depression: Part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups. Psychiatry Res 34(1):43–57

    Article  CAS  PubMed  Google Scholar 

  113. Maes M, Cosyns P, Maes L, D'Hondt P, Schotte C (1990) Clinical subtypes of unipolar depression: Part I. A validation of the vital and nonvital clusters. Psychiatry Res 34(1):29–41

    Article  CAS  PubMed  Google Scholar 

  114. Kanchanatawan B, Sriswasdi S, Thika S, Sirivichayakul S, Carvalho AF, Geffard M, Kubera M, Maes M (2018) Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning. Metab Brain Dis 33:1053–1067. https://doi.org/10.1007/s11011-018-0208-4

    Article  PubMed  Google Scholar 

  115. Zachar P, Stoyanov DS, Aragona M, Jablensky A (eds) (2014) Alternative perspectives on psychiatric validation: DSM, ICD, RDoC, and beyond. OUP, Oxford

    Google Scholar 

  116. Kendler KS, Parnas J (eds) (2015) Philosophical issues in psychiatry: explanation, phenomenology, and nosology. JHU Press

  117. Akiskal HS (2003) Validating 'hard' and 'soft' phenotypes within the bipolar spectrum: continuity or discontinuity? J Affect Disord 73(1–2):1–5

    Article  PubMed  Google Scholar 

  118. Maes M, Maes L, Schotte C, Vandewoude M, Martin M, D'Hondt P, Blockx P, Scharpé S et al (1990) Clinical subtypes of unipolar depression: Part III. Quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Psychiatry Res 34(1):59–75

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank the Centre of Approach and Treatment for Smokers, Psychiatric Unit at UEL, Clinical Laboratory of the University Hospital and Laboratory of Research and Graduate College Hospital (LPG), Brazil.

Authorships

All authors contributed to the writing up of the paper. The work was designed by SOVN, MM, DSB, JBM, and HOV. Data were collected by SOVN, HOV, AC, and JBM. Laboratory analyses were conducted by KLB, APM, and DSB. Statistics were performed by MM. AFC revised the manuscript and provided relevant intellectual content. All authors revised and approved the final draft.

Funding

This study was supported by Health Sciences Postgraduate Program at Londrina State University, Parana, Brazil (UEL), and Ministry for Science and Technology of Brazil (CNPq). CNPq number 470344/2013-0 and CNPq number 465928/2014-5. MM is supported by a CNPq—PVE fellowship and the Health Sciences Graduate Program fellowship, State University of Londrina.

Author information

Authors and Affiliations

  1. Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Av. Robert Koch, Londrina, PR, 60 86035-380, Brazil

    Michael Maes, Juliana Brum Moraes, Ana Congio, Kamila Landucci Bonifacio, Decio Sabbatini Barbosa, Heber Odebrecht Vargas, Ana Paula Michelin & Sandra Odebrecht Vargas Nunes

  2. Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand

    Michael Maes

  3. Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria

    Michael Maes

  4. IMPACT Strategic Research Centre, School of Medicine, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia

    Michael Maes

  5. Department of Psychiatry, University of Toronto, Toronto, ON, Canada

    Andre F. Carvalho

  6. Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada

    Andre F. Carvalho

Authors
  1. Michael Maes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juliana Brum Moraes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Congio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kamila Landucci Bonifacio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Decio Sabbatini Barbosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Heber Odebrecht Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ana Paula Michelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andre F. Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sandra Odebrecht Vargas Nunes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Maes.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maes, M., Moraes, J.B., Congio, A. et al. Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress. Mol Neurobiol 56, 6626–6644 (2019). https://doi.org/10.1007/s12035-019-1552-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-019-1552-z

Keywords

Search

Navigation